amgen maritide glp-1 drug comparison Amgen's weight-loss fails to impress in study; shares plunge Amgen says obesity drug MariTide

This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side Effects provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects

A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a persons risk of other health conditions.

evidence from uncontrolled designs (case reports, case series, pharmacovigilance analyses) was initially rated very low certainty, as these designs are inherently uncontrolled and start below the lowest GRADE tier

adults have obesity, with the rate increasing more than 10 percentage points in the past 2 decades

GLP-1 medications can provide major health benefits, but recent studies have raised questions about a possible link with NAION, a rare optic nerve condition that can cause sudden vision loss